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Abstract
Introduction:  Hyperbilirubinemia  is  a  common  health  problem  in  newborns.  Its  effects  can
be different  according  to  the  level  and  duration  of  the  hyperbilirubinemia.  The  toxic  effect
of bilirubin  on  the  auditory  system  can  be  seen  as  a  sensory  neural  hearing  loss  or  auditory
neuropathy  spectrum  disorder  (ANSD).
Objective:  The  purpose  of  our  study  was  to  determine  the  effects  of  toxic  bilirubin  level  on  the
auditory system  by  using  Auditory  Brainstem  Response  audiometry.
Methods:  Rats  are  used  as  animal  models  due  to  their  low  cost  and  easy  attainability.  Audi-
tory Brainstem  Response  was  used  for  auditory  assessment.  In  this  study,  three  groups  were
established:  experimental,  control  and  placebo  groups.
Results:
Results:  In  the  experimental  group,  which  consists  of  rats  with  hyperbilirubinemia,  sensory
neural hearing  loss  was  found  bilaterally  in  4  rats  (66.67%)  and  unilaterally  in  2  rats  (16.67%)
and auditory  neuropathy  spectrum  disorder  was  found  unilaterally  in  1  rat  (8.33%).  Auditory
Brainstem Response  thresholds  were  signiﬁcantly  elevated  compared  to  control  and  placebo
groups (p  <  0.05).
 Please cite this article as: Gökdog˘an C¸, Genc¸  A, Gülbahar Ö, Gökdog˘an O, Helvacı A, Bezgin SÜ, et al. Auditory evoked potentials in a
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Conclusion:  Hyperbilirubinemia  of  newborn  rats  may  result  both  in  sensory  neural  hearing  loss
and auditory  neuropathy  spectrum  disorder.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license
(https://creativecommons.org/licenses/by/4.0/).
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Potenciais  evocados  auditivos  em  um  modelo  de  rato  Wistar  neonato  com
hiperbilirrubinemia
Resumo
Introduc¸ão: A  hiperbilirrubinemia  é  um  problema  de  saúde  comum  em  neonatos.  Seus  efeitos
podem variar,  dependendo  do  nível  e  da  durac¸ão  da  hiperbilirrubinemia.  O  efeito  tóxico  da  bilir-
rubina no  sistema  auditivo  pode  ser  observado  na  forma  de  deﬁciência  auditiva  sensorioneural
ou de  distúrbio  do  espectro  da  neuropatia  auditiva.
Objetivo:  A  ﬁnalidade  de  nosso  estudo  foi  determinar  os  efeitos  de  nível  tóxico  de  bilirrubina
no sistema  auditivo,  com  o  uso  da  audiometria  da  resposta  auditiva  evocada  de  tronco  cerebral.
Método: Os  ratos  são  empregados  como  modelos  animais  grac¸as  a  seu  baixo  custo  e  fácil
obtenc¸ão. Utilizamos  a  resposta  auditiva  evocada  de  tronco  cerebral  para  avaliac¸ão  da  audic¸ão.
No estudo,  foram  estabelecidos  três  grupos:  experimental,  controle  e  placebo.
Resultados:  No  grupo  experimental,  constituído  de  ratos  com  hiperbilirrubinemia,  disacusia
auditiva neurosensorial  foi  diagnosticada  bilateralmente  em  quatro  ratos  (66,67%),  e  unilat-
eralmente em  dois  (16,67%);  e  distúrbio  do  espectro  da  neuropatia  auditiva  foi  observado
unilateralmente  em  um  rato  (8,33%).  Os  limiares  da  resposta  evocada  de  tronco  cerebral
estavam signiﬁcantemente  elevados,  em  comparac¸ão  com  os  grupos  controle  e  placebo  (p  <
0,05).
Conclusão:  A  hiperbilirrubinemia  de  ratos  neonatos  pode  resultar  tanto  em  disacusia  auditiva
neurosensorial  como  em  distúrbio  do  espectro  da  neuropatia  auditiva.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publi-
cado por  Elsevier  Editora  Ltda.  Este  é  um  artigo  Open  Access  sob  a  licença  CC  BY
(https://creativecommons.org/licenses/by/4.0/deed.pt).
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Three  groups  have  been  included  in  the  study,  as  experi-Introduction
Hyperbilirubinemia  is  a  common  health  problem  of  new-
borns.  Newborn  hyperbilirubinemia  has  been  accepted  as
one  of  the  main  risk  factors  in  infants’  hearing  loss  since  the
1900s.1 Effects  of  hyperbilirubinemia  on  hearing  function
can  be  different  according  to  the  level  of  hyperbilirubine-
mia  and  duration  of  hyperbilirubinemia.2 It  is  known  that  a
high  bilirubin  level  is  a  risk  factor  for  sensory  neural  hear-
ing  loss  (SNHL)  and  auditory  neuropathy  spectrum  disorders
(ANSD).3
SNHL  results  from  pathology  in  the  cochlea,  8th  nerve,
brain  stem  or  cortex  level.  Although  50%  of  SNHL  in
children  is  genetic,  it  can  also  develop  depending  on
pathologies  in  the  prenatal,  natal,  or  postnatal  periods
(infections,  metabolic  disorders  etc.).4 In  postnatal  periods
hyperbilirubinemia  is  the  most  common  SNHL  cause  for
newborns,  and  SNHL  prevalence  depending  on  hyperbiliru-
binemia  in  newborns  and  infants  has  been  determined  as
12.8%.5
ANSD  is  an  issue  that  has  many  unknown  aspects  and  it
is  widely  studied.  In  some  cases  of  ANSD,  while  only  the
inner  hair  cells  in  the  inner  ear  are  affected,  in  some  other
cases  only  the  central  auditory  pathway  is  affected.  Among
the  ANSD  risk  factors  are  hyperbilirubinemia,  premature
birth,  and  genetic,  perinatal  mechanical  ventilation.  ANSD
m
b
gelated  to  hyperbilirubinemia  is  seen  in  2.7%  of  newborns
ith  hyperbilirubinemia.6
Hyperbilirubinemia  may  have  different  pathological
ffects  on  the  ABR  pattern  of  affected  individuals.  In  new-
orns  with  hyperbilirubinemia,  the  ABR  pattern  can  either
o  back  to  normal  or  become  even  more  pathological  after
lood  bilirubin  levels  are  brought  to  normal  with  treatment.7
yperbilirubinemia  in  the  newborn  period  has  been  previ-
usly  studied  with  rat  model.8,9
The  purpose  of  our  study  is  to  determine  the  effects  of
oxic  bilirubin  level  on  the  auditory  system  by  using  Auditory
rainstem  Response  audiometry.
ethod
he  study  has  been  conducted  in  the  local  Experimental
nimals  Research  and  Application  Center  of  the  Faculty
f  Medicine.  The  approval  of  the  ethical  board  has  been
aken  (number  of  approval  of  the  ethics  committee:  G.Ü.ET-
2.001).ent,  placebo  and  control  groups  and  6  newborn  rats  have
een  used  for  each  group.  The  number  of  rats  in  each
roup  was  restricted  by  the  ethics  committee.  The  ear
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xamination  of  all  rats  has  been  performed  with  endoscopes
y  an  otorhinolaryngologist.
xperiment  group
he  experiment  group  consisted  of  6  newborn  Wistar  Albino
ale  rats  with  hyperbilirubinemia,  with  weights  between  18
nd  20  g  (average:  18.33  g).  A  Rat  Hyperbilirubinemia  Model
as  been  created  for  the  experiment  group.
The  method  for  establishing  hyperbilirubinemia  was  sim-
lar  to  methods  previously  reported.9 Bilirubin  (Sigma,  St.
ouis,  MO;  B4126)  was  stored  in  the  dark,  and  the  solu-
ion  was  prepared  just  before  the  injection.  Bilirubin  was
hawed  in  0.1%  M  NaOH  just  as  in  Hansen  et  al.8 applica-
ion  and  stabilized  with  BSA  and  diluted  with  Krebs-Ringer
uffer  (pH:  7.4).  The  bilirubin  concentration  has  been  deter-
ined  as  3  mg/mL,  and  the  prepared  solution  has  been
reserved  at  +40 ◦C,  in  a  shaded  place.  Each  animal  in
he  experimental  group  received  an  intraperitoneal  injec-
ion  of  bilirubin  at  50  mg/kg  on  the  postnatal  7th  and
0th  days.  Prior  to  the  1st  injection  and  24  h  after  the
st  and  2nd  bilirubin  injections,  measurements  have  been
one  through  Transcutaneous  Bilirubinometry  (TcB)  over  the
kin,  in  order  to  determine  the  bilirubin  level.  On  the  21st
ay,  electrophysiological  hearing  tests  and  TcB  were  per-
ormed  after  intramuscular  anesthesia  (50  mL/kg  ketamine
nd  10  mL/kg  xylazine).  Then  euthanasia  was  performed
y  drawing  intracardiac  blood  under  deep  anesthesia.  The
erum  bilirubin  level  was  determined  quantitatively  from
he  intracardiac  blood  drawn  and  was  compared  to  TcB.
lacebo  group
he  placebo  group  consisted  of  6  newborn  Wistar  Albino
ale  rats  with  weights  between  18  and  20  g  (average:
8.3  g).  As  the  placebo  solution,  BSA  and  24  mg/mL  Krebs-
inger  buffer  (pH:  7.5)  have  been  used.  The  prepared
olution  has  been  preserved  in  +40 ◦C,  in  a  shaded  place.  In
rder  to  determine  whether  it  has  an  effect  on  the  hearing
ystem  of  rats,  the  solution  which  has  been  prepared  without
ilirubin  has  been  applied  in  exactly  the  same  dosage  which
as  been  applied  to  the  experiment  group.  The  placebo  solu-
ion  has  been  given  in  the  same  procedure  applied  on  the
ats  in  the  experiment  group  and  has  been  subjected  to  the
ame  processes.
ontrol  group
he  control  group  consisted  of  6  newborn  Wistar  Albino  male
ats  with  weights  between  18  and  20  g  (average:  19  g).  Con-
rary  to  the  experiment  and  placebo  groups,  the  rats  in  the
ontrol  group  have  not  been  given  any  injections.  However,
n  order  to  determine  their  bilirubin  levels,  coordinated
valuations  have  been  performed  with  the  time  slices  deter-
ined  for  the  experiment  and  placebo  groups  and  they  have
een  subjected  to  the  same  processes.uditory  Brainstem  Response  (ABR)  test
he  ABR  evaluations  of  the  rats  included  in  the  study
ave  been  performed  with  the  Bio-Logic  Systems  Corp.’s
r
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avigator  Pro  Model  (version  2.2.0)  device.  In  the  ABR  eval-
ations,  13.00  rate  click  stimulus,  10  msn  analysis  time,
000  sweep  in  averaging,  100--1500  Hz  ﬁltration  have  been
sed.  Changes  in  the  intensity  have  been  made  in  accor-
ance  with  the  responses  achieved  in  the  70  dB  nHL  intensity
evel  recordings.  In  order  to  determine  the  CM  existence,  the
ondensation  (+)  rarefaction  (−)  polarity  change  has  been
pplied  in  the  same  intensity  for  both  ears.  For  the  thresh-
ld  scan,  as  it  is  advised  in  the  click  stimulus,  it  has  been
ontinued  with  rarefaction  polarity.
ranscutaneous  Bilirubin  (TcB)  measurement
ranscutaneous  Bilirubinometry  (TcB)  has  been  performed
ith  Minolta/Air  --  Shields  Jaundice  Meter  (JM,  mode  101,
inolte  Corero  Co,  Osaka,  Japan).  TcB  measurement  has
een  performed  on  the  back  area  of  the  rats.  Prior  to  the
easurement,  technical  maintenance  and  calibration  of  the
evice  has  been  performed.  During  the  measurements,  due
o  the  pressure  applied  by  the  probe,  an  acrylic  plaque  was
ade  to  prevent  the  rats  from  being  damaged.
erum  Total  Bilirubin  (STB)  measurement
erum  Total  Bilirubin  levels  have  been  analyzed  using  ready-
ade  kits  (Roche)  in  auto  analyzer  (Roche/Integra-800)
ystems.  The  total  bilirubin  measurement  principle  of  this
it  is  the  Diazo  method  based  on  the  measurement  of  the
mount  of  azobilirubin,  which  is  the  result  of  the  reaction
f  bilirubin  and  diazotized  sulfanilic  acid.10
tatistical  evaluation
tatistical  analysis  has  been  realized  in  SPSS  for  Windows
ersion  16.0  packaged  software.  The  TcB  results  used  to
etermine  the  bilirubin  levels  in  the  groups  have  been
ompared  with  the  STBL,  ABR  ﬁndings  for  the  hearing  eval-
ation  differences  in  the  groups,  hasn’t  been  normally
istributed  the  Kruskal--Wallis  Variance  analysis  has  been
pplied.  The  level  of  signiﬁcance  has  been  taken  as  p  <  0.05.
he  Mann--Whitney  U  test  has  been  performed  to  test  the
igniﬁcance  of  pair  wise  differences  using  Bonferroni  correc-
ion  to  adjust  for  multiple  comparisons  (0.05/3  =  0.016).  An
verall  5%  type  I  error  level  has  been  used  to  infer  statistical
igniﬁcance.  The  correlation  coefﬁcient  of  the  relationships
etween  the  variables  in  the  groups  and  statistical  signiﬁ-
ance  has  been  calculated  by  the  Spearman  test.  An  overall
%  type  I  error  level  has  been  used  to  infer  statistical  signif-
cance.
esults
evels  of  Transcutaneous  Bilirubinometry  (TcB)  and
erum Total  Bilirubin
hile  the  comparison  of  the  groups  in  terms  of  the  TcB
esults  (Table  1) prior  to  the  bilirubin  injection  has  not  been
bserved  to  be  statistically  meaningful  (p  >  0.05),  the  TcB
esults  performed  24  h  after  the  1st  and  2nd  bilirubin  injec-
ions  show  that  there  is  a  statistically  higher  level  of  bilirubin
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Table  1  TcB,  STB  (mg/dL)  values  and  ABR  (dBnHL)  thresholds  of  rats.
Rats  Groups  TcB1  TcB2  TcB3  TcB4  STB  ABR  right  ABR  left
1 Experiment 0.01  0.89  0.72  0.56  0.61  30  40
2 0.01  0.86  0.62  0.4  0.23  30  30
3 0.02  0.92  0.7  0.2  0.15  10  10
4 0.01  0.96  0.69  0.5  0.58  NR  NR
5 0.03  0.72  0.4  0.28  0.23  20  30
6 0.02  0.9  0.74  0.62  0.69  40  50
1 Placebo 0.01 0.03 0.02  0.38  0.46  20  0
2 0.01 0.02 0.04 0.4 0.43  NR  NR
3 0.02 0.05 0.04 0.28 0.33 20  20
4 0.02  0.02  0.05  0.22  0.3  −10  0
5 0.01  0.05  0.03  0.38  0.44  10  10
6 0.01  0.02  0.04  0.3  0.42  10  10
1 Control 0.03 0.03  0.04  0.06  0.08  NR  NR
2 0.01 0.01 0.03 0.15  0.17  20  10
3 0.01 0.01 0.02 0.1  0.17  10  20
4 0.01 0.01 0.02 0.02  0.03  10  20
5 0.02 0.02 0.04 0.09 0.15  10  10
6 0.01  0.01  0.03  0.1  0.17  10  0
ts performed 24 h after the 1st and 2nd bilirubin injections; TcB4 value
Figure  1  Example  for  Category  1  (normal  ABR  pattern).TcB1, before bilirubin injection; NR, no response; TcB2 and 3 resul
prior to euthanasia.
(p  <  0.05)  in  the  rats  in  the  experiment  groups  compared
to  the  rats  in  the  placebo  and  control  groups.  When  the
STBL  in  blood  is  compared  between  the  groups,  it  has  been
observed  that  it  is  higher  in  statistically  signiﬁcant  terms
in  the  experiment  groups  in  comparison  to  the  placebo  and
control  groups.  It  has  been  observed  that  there  is  a  statis-
tically  signiﬁcant  positive  and  strong  relationship  between
the  TcB  value  prior  to  euthanasia  and  the  STBL  value  in  the
experiment,  placebo  and  control  groups.
Auditory  Brainstem  Responses  (ABR)
Threshold  results
The  comparison  of  ABR  between  the  groups,  one  way  vari-
ance  analysis  has  been  used.  According  to  the  results  of
the  analysis,  while  right  ear  ABR  threshold  average  does
not  show  any  signiﬁcant  difference  between  the  groups
(p  >  0.05),  left  ear  ABR  threshold  shows  a  statistically  signif-
icant  difference  between  groups  (p  <  0.05).  This  difference
is  a  result  of  the  fact  that  the  left  ear  threshold  intensity  of
the  rats  in  the  experiment  groups  is  higher  compared  to  the
other  two  groups  (p  <  0.016)  (Tables  1  and  2).  For  the  test
of  the  relationship  between  the  STBL  values  in  the  study
groups  and  ABR  thresholds,  Spearman’s  rho  coefﬁcient  has
been  calculated  between  the  variables.  According  to  the
results,  there  is  no  signiﬁcant  level  of  relationship  between
the  ABR  left  and  right  threshold  values  with  the  STBL  value
in  terms  of  the  groups.
In  the  evaluation  of  the  CM  existence  in  the  ABR  pattern
achieved  from  the  groups,  four  aspects  have  been  note-
worthy.  CM  ﬁndings  have  been  categorized  by  taking  these
observed  aspects  as  a  basis.  In  Category  1  (Fig.  1),  while  CM
has  not  been  achieved  with  the  normal  ABR  pattern;  in  Cat-
egory  2  (Fig.  2),  CM  has  been  observed  without  the  2nd  wave
(the  ABR  threshold  was  considered  to  be  the  lowest  intensity
Figure  2  Example  for  Category  2  (Cochlear  Microphonic  pat-
tern without  ABR  threshold).
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Table  2  Mean  threshold  of  ABR  in  right  and  left  ears  (dB  nHL).
Group  Mean  SD  Median  Min--max
Right  ear  Control  12.00  4.47  10  10--20
ABR threshold  Placebo  10.00  12.25  10  −10--20
Experiment  26.00  11.40  30  10--40
Left ear  Control  12.00  8.37  10  10--20
ABR threshold  Placebo  8.00  8.37  10  0--20
Experiment  32.00  
Figure  3  Example  for  Category  3  (normal  ABR  with  Cochlear
Microphonic).
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nigure  4  Example  for  Category  4  (the  broken  wave  morphol-
gy including  the  2nd  wave  Cochlear  Microphonic).
t  which  a  deﬁnite  repeatable  response  peak  II  was  present).
n  addition,  the  category  achieved  in  the  2nd  wave  with  the
M  has  been  evaluated  as  Category  3  (Fig.  3)  and  the  broken
ave  morphology  including  the  2nd  wave  with  the  CM  has
een  evaluated  as  Category  4  (Fig.  4).
iscussion
yperbilirubinemia  is  an  important  health  problem  in  new-
orns.  The  hearing  system  is  also  sensitive  to  bilirubin
oxicity.  The  damages  in  the  central  auditory  areas  have
een  deﬁned  in  both  animals  and  humans  with  hyperbiliru-
inemia  in  anatomical  and  functional  terms.  However,  the
hysiological  effects  and  neuromechanism  of  the  damages
aused  by  hyperbilirubinemia  in  the  peripheral  auditory
rgans  are  still  a  mystery.
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It  has  been  stated  in  the  literature  that  ANSD  may  be
bserved  in  1/3--1/2  of  the  cases  with  a  high  level  of
yperbilirubinemia.11,12 SNHL  may  also  be  observed  in  hyper-
ilirubinemia  (12.8%).5
Bilirubin  toxicity  is  closely  related  to  STBL.  While  a  high
orrelation  is  observed  between  level  of  bilirubin  in  humans
nd  SNHL,  this  correlation  decreases  in  ANSD;  although  in
evels  higher  than  20  mg/dL  the  possibility  of  observing  ANSD
ncreases.3 There  are  limited  publications  which  deﬁne  such
eﬁnite  differences  and  relationships  with  pathologies  in
nimal  models.  Due  to  the  difﬁculties  and  limitation  in
orming  animal  models,  it  is  difﬁcult  to  clearly  determine
ilirubin  levels  and  pathologies  resulting  from  this.13
In  the  forming  of  a  rat  model  with  hyperbilirubinemia,
ilirubin  injection  is  frequently  resorted  to,  due  to  the
asiness  of  access  and  application  and  achieving  absorbed
eurotoxicity  in  the  circulatory  system  in  a  short  time.13,14
ao  et  al.,14 in  their  study  conducted  in  2011,  have  stated
hat  free  bilirubin  application  is  efﬁcient  in  utilization  in
oth  hyperbilirubinemia  and  formation  of  ANSD.  For  this  rea-
on,  intra-abdominal  bilirubin  injection  has  been  preferred
n  the  formation  of  rat  model  with  hyperbilirubinemia  in  this
tudy.
Hai  Bo  Ye  et  al.13 state  that,  in  cases  where  a  single
nd  low  dosage  bilirubin  injection  is  done  in  animal  models,
he  damage  is  not  long  lasting  and,  for  this  reason,  high
nd  repetitive  dosages  may  be  more  effective  in  determin-
ng  the  long  term  effects  of  hyperbilirubinemia.  However,
esearchers  also  underline  the  fact  that  the  highest  risk  in
hese  manipulations  is  mortality.  In  the  study,  after  it  was
upported  with  pre-studies,  Hansen  et  al.8 model  has  been
sed,  and  bilirubin  dosage  appropriate  for  the  weight  of  the
ewborn  rats  and  which  does  not  cause  mortality  has  been
etermined.
As  Wennberg  et  al.15 state,  due  to  the  insufﬁciency  of
pproach  methods  in  the  monitoring  of  STBL  in  newborn
xperiment  animals,  it  is  difﬁcult  to  form  a  relationship
etween  the  bilirubin  level  and  neurotoxicity.  In  the  liter-
ture,  there  are  no  publications  which  state  STBL  in  terms
f  newborn  rats.  The  most  important  reason  for  this  is  that
he  blood  amount  in  newborn  rats  is  very  low  (for  instance,
t  is  about  1  cc  in  a  rat  that  is  1  week  old)  and  that  the
ats  die  when  this  blood  is  taken.  This  also  causes  an  impor-
ant  problem  in  ethical  terms.  However,  the  TcB  method
sed  to  determine  the  bilirubin  level  in  humans,  which  is
on-invasive,  can  also  be  used  in  rats  as  well  as  newborns.
t  is  stated  in  literature  that  the  TcB  results  are  similar
o  the  results  of  the  total  serum  bilirubin  level  in  blood.
lthough  it  is  more  reliable  to  observe  the  STBL  in  blood,
t  is  stated  that  TcB  can  be  used  as  an  alternative.16 In
f  hyp
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the  study,  periodical  measurements  have  been  done  through
transcutaneous  bilirubinometry  until  euthanasia,  in  order  to
determine  the  bilirubin  levels  of  rats.  The  bilirubin  level
determined  through  the  measurements  prior  to  euthanasia
and  STBL’s  in  blood  taken  through  intracardiac  methods  after
euthanasia  have  been  compared  and  a  signiﬁcant  relation-
ship  has  been  determined  in  line  with  the  literature.
It  is  stated  that  the  TcB  values  reach  the  maximum  level
24--48  h  after  the  bilirubin  injection  in  Wistar  Albino  rats
and  that  these  values  decrease  by  time.8,9 According  to  the
TcB  data  achieved  in  the  study,  the  high  level  of  bilirubin  in
the  experiment  group  being  signiﬁcantly  higher  compared
to  other  groups  is  an  important  indication  that  bilirubin  tox-
icity  was  almost  reached.  The  relative  increase  of  the  TcB
measurement  results  prior  to  euthanasia  in  all  groups  may
be  explained  with  the  variability  in  the  bilirubin  values  in
blood  until  adulthood.
In  newborns,  ABR  is  frequently  preferred  in  the  deter-
mination  of  the  effect  of  bilirubin  toxicity  on  the  auditory
system.  ABR,  which  is  used  in  the  evaluation  of  auditory  sen-
sitivity,  is  preferred  in  newborns  due  to  its  being  objective
and  non-invasive;  its  reliability  being  higher  compared  to
other  test  methods  and  determination  of  CM  in  the  identiﬁ-
cation  of  ANSD.17--19
In  studies  conducted  on  rats  with  hyperbilirubinemia,
while  differences  such  as  latency  elongation  and  decrease
in  amplitude  in  ABR  have  been  evaluated,  threshold  evalu-
ation  has  also  been  done  along  with  these  variables  and  it
has  been  observed  that  there  are  signiﬁcant  increases  in  the
thresholds  of  their  ABR’s.13,14,19,20 In  the  study,  while  values
close  to  normal  data  and  morphology  have  been  determined
in  the  rats  of  the  control  group  with  the  exception  of  1
rat,  an  increase  in  the  threshold  values  of  the  ABR  ﬁnd-
ings  and  deterioration  in  morphology  have  been  observed
in  the  placebo  and  experiment  groups.  In  the  experiment
group,  while  compatible  ﬁndings  have  been  achieved  in  the
CM  record  and  ANSD  of  1  rat  in  one  ear,  it  has  not  been
possible  to  receive  ABR  response  without  CM  record  in  the
other  ear.  In  other  rats,  deteriorations  in  the  ABR  have  been
observed  in  different  patterns.
In  rats,  the  anatomical  settlement  in  ABR  waves  dif-
fers  from  the  humans.  In  humans,  while  the  1st  and  2nd
waves  originate  from  the  8th  nerve  and  the  3rd  wave  ori-
ginates  from  the  CN,  it  is  known  that  in  rats  the  1st  and
2nd  waves  originate  from  the  CN  and  the  3rd  wave  origi-
nates  from  SOC.21--23 The  deteriorations  observed  in  the  CN
in  the  morphological  evaluation  conducted  in  the  rats  in  the
experiment  group  are  thought  to  cause  deteriorations  in  the
morphology  of  the  ABR  responses  in  this  group  as  well.13,14,19
Shapiro  et  al.24 state  that  acute  bilirubin  toxicity  especially
changes  the  ABR’s  signiﬁcantly  in  the  ﬁrst  4  h  in  Gunn  Rats.
In  the  studies  conducted  on  newborns  with  hyper-
bilirubinemia,  it  has  been  stated  that  there  has  been
a  spontaneous  improvement  in  about  50%  without  any
interventions  in  the  patterns  where  ABR  has  not  been
achieved  and  CM  has  been  observed.16 In  addition,  the
neural  damage  in  the  auditory  brain  stem,  which  causes
ABR  change,  decreases  the  synchronization  formed  by  the
activation  of  the  auditory  neurons.  Thus,  the  membrane
potential  of  the  auditory  neurons  decrease  and  neural
function  in  the  auditory  brain  stem  is  corrupted  due  to
hyperbilirubinemia.13,14,19,20,25 In  our  study,  due  to  bilirubin
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njections  being  done  prior  to  the  formation  of  blood--brain
arriers  in  the  newborn  rats,  their  need  for  maternal  care
ntil  adulthood  and  the  risk  of  mortality  becoming  higher
hen  they  are  taken  away  from  their  mothers,  or  during
nesthesia,  ABR  evaluations  have  not  been  done  immedi-
tely  after  the  injections.  For  this  reason,  the  acute  effect
f  bilirubin  toxicity  and  its  follow-up  were  not  evaluated  as
ell.
In  the  literature,  while  the  difﬁculty  of  long  term  follow-
p  in  animal  studies  is  underlined,  it  is  also  noteworthy
hat  the  results  related  to  this  are  not  mentioned.  In  the
tudy,  after  the  2nd  dose  injection,  we  waited  for  11  days,
ntil  the  rats  reached  adulthood.  During  this  time,  it  is
hought  that  the  potential  effects  of  the  hyperbilirubinemia
ecrease.  However,  although  the  effect  of  hyperbilirubine-
ia  has  decreased,  as  it  can  be  seen  from  the  study  as  well,
ue  to  achieving  high  intensity  ABR  thresholds  in  line  with
he  bilirubin  level,  this  is  thought  to  cause  deteriorations
n  the  wave  morphology  and  in  being  able  to  achieve  ANSD
ndings  and/or  ABR.
Podwall  et  al.26 state  that,  without  any  risk  factor,  they
ave  published  a  pattern  that  has  determined  ANSD  in  the
eft  ear  with  normal  radiological  ﬁndings,  and  although
ilirubin  toxic  effect  was  systemic,  unilateral  results  can
lso  be  observed  depending  on  involvement  localization.
During  the  formation  of  the  model,  due  to  the  fact  that
esides  the  rat  type  used,  the  powder  bilirubin  used  was
he  same  in  the  formation  of  hyperbilirubinemia,  Hansen
t  al.8 model  has  been  used.  Due  to  the  fact  that  the  same
olution  has  been  used  in  the  placebo  group  in  the  literature,
 pre-study  related  to  the  solution’s  effects  on  the  auditory
ystem  has  not  been  conducted.  However,  in  the  evaluation
f  ﬁndings  related  to  the  placebo  group,  similar  results  have
een  achieved  in  the  ABR  evaluations  of  some  rats  compared
o  the  rats  in  the  experiment  group.
When  it  is  taken  into  consideration  that  the  STBL  values
re  not  high  in  the  TcB  of  this  group,  it  gives  rise  to  the
hought  that  the  solution  is  effective  on  the  auditory  sys-
em  as  well.  This  ﬁnding,  which  may  be  accepted  as  the
eak  point  of  the  study,  also  provides  very  valuable  infor-
ation  in  terms  of  showing  understanding  of  the  real  effect
f  hyperbilirubinemia  on  the  auditory  system,  by  studying
he  effect  of  the  solution  to  be  used  in  the  formation  of
yperbilirubinemia  in  animal  models.
As  in  the  study  hypothesis,  the  blood  bilirubin  levels
ave  been  allowed  to  increase  by  injecting  toxic  dosages
f  bilirubin  to  newborn  rats,  and  it  has  been  observed  that
yperbilirubinemia  may  cause  SNHL  and/or  ANSD.  Besides
his,  it  has  also  been  found  noteworthy  that  the  effects  of
yperbilirubinemia  may  appear  in  different  patterns  in  ABR.
onclusion
n  our  study,  by  forming  rat  model  for  newborns  with  hyper-
ilirubinemia  through  a  toxic  dose  of  bilirubin,  the  effects
f  level  of  bilirubin  on  infants  and  children  under  risk,  the
esults  of  the  electrophysiological  hearing  evaluations  and
orphological  difference  have  been  analyzed.
It  has  been  observed  that  hyperbilirubinemia  can
ncrease  the  ABR  threshold  in  its  long  term  effects  and
eteriorate  wave  morphology.  It  has  been  taken  under
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onsideration  that  the  deterioration  of  wave  morphology
n  ABR  may  be  connected  to  the  decrease  of  synchroniza-
ion  formed  by  the  neural  damage  in  the  auditory  brainstem
nd  the  activation  of  auditory  neurons.  It  has  been  observed
hat  hyperbilirubinemia  may  cause  ANSD  as  well  as  SNHL  and
M  can  be  observed  without  the  ABR  response,  and  that  in
ystemic  applications  not  only  bilateral  but  also  unilateral
ettlements  may  exist.
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